Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Enhanced glycemic control with combination therapy for type 2 diabetes in primary care.

Kuritzky L, Samraj GP.

Diabetes Ther. 2011 Sep;2(3):162-77. doi: 10.1007/s13300-011-0006-z. Epub 2011 Aug 1.

2.

Managing type 2 diabetes: going beyond glycemic control.

Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.

J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19.

PMID:
18597582
3.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
4.

New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.

Braunstein S.

Clin Ther. 2003 Jul;25(7):1895-917. Review.

PMID:
12946541
5.
6.

Combination therapy for type 2 diabetes.

Mudaliar S, Henry RR.

Endocr Pract. 1999 Jul-Aug;5(4):208-19.

PMID:
15251678
8.

Community-based care for the management of type 2 diabetes: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(23):1-40. Epub 2009 Oct 1.

10.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
11.

Practical strategies to improve treatment of type 2 diabetes.

Fleury-Milfort E.

J Am Acad Nurse Pract. 2008 Jun;20(6):295-304. doi: 10.1111/j.1745-7599.2008.00323.x. Review.

PMID:
18588656
12.

Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003639. Review.

PMID:
15846673
13.
14.

Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.

Bailey T.

Am J Med. 2013 Sep;126(9 Suppl 1):S10-20. doi: 10.1016/j.amjmed.2013.06.009. Review.

PMID:
23953074
15.
16.

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

Ann Intern Med. 2005 Oct 18;143(8):549-58.

PMID:
16230721
17.

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS.

Endocr Pract. 2009 Sep-Oct;15(6):540-59. Erratum in: Endocr Pract. 2009 Nov-Dec;15(7):768-70.

PMID:
19858063
18.

Type 2 diabetes mellitus: what is the optimal treatment regimen?

Bell DS.

Am J Med. 2004 Mar 8;116 Suppl 5A:23S-29S. Review.

PMID:
15019860
19.

Achieving glycemic goals with addition of incretin-based therapies to insulin in patients with type 2 diabetes mellitus.

Tibaldi J.

Am J Med Sci. 2014 Jun;347(6):491-501. doi: 10.1097/MAJ.0000000000000202. Review.

PMID:
24469234
20.

THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES.

Bode BW, Garg SK.

Endocr Pract. 2016 Feb;22(2):220-30. doi: 10.4158/EP15869.RA. Epub 2015 Oct 20. Review.

PMID:
26484403

Supplemental Content

Support Center